A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: inside (292)

Data breach - questions and answers

Description
• How did this happen? The Freedom of Information Act 2000 provides the public access to information held by public authorities. The
Url
/Media/UHS-website-2019/Docs/News/Data-breach-questions-and-answers.pdf

Avelumab-Axitinib

Description
Chemotherapy Protocol RENAL CELL AVELUMAB-AXITINIB Regimen • Renal Cell - Avelumab-Axitinib Indication • Unresectable
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Axitinib-Avelumab.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Reg
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Ca
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/CarboplatinAUC5-Paclitaxel-21day.pdf

SoAR NMAHP-HCS ACDL JD 2022

Description
Southampton Academy of Research (SoAR) Academic Career Development Lead for Nurses, Midwives and Allied Health Professionals (NMAHPs) & Heal
Url
/Media/Southampton-Clinical-Research/Downloads/SoAR-NMAHP-HCS-ACDL-JD-2022.pdf

Annual complaints report 2020-21

Description
ANNUAL COMPLAINTS REPORT 2020/21 RETROSPECTIVE PERFORMANCE LOOKING FORWARDS “All patients, from every background and walk of
Url
/Media/UHS-website-2019/Patientinformation/Contactingus/Annual-complaints-report-2020-21.pdf

Osimertinib

Description
Chemotherapy Protocol Lung cancer - Non-small cell (NSCLC) OSIMERTINIB Regimen • NSCLC - Osimertinib Indication • Osimertinib is available as an option within the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Osimertinib.pdf

Afatinib Ver 1

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Regimen AFATINIB NSCLC - Afatinib Indication Treatment of locally advanced or meta
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AfatinibVer1.pdf

Atezolizumab(1680-28days)

Description
Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab (1680mg-28 days) Regimen • Urothelial– Atezolizumab (1680mg-2
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab1680-28days.pdf

Kadcyla (Trastuzumab emtansine) v1

Description
Chemotherapy Protocol BREAST CANCER KADCYLA (trastuzumab emtansine) Kadcyla (trastuzumab emtansine) is NOT the same drug
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Kadcyla-Trastuzumab-emtansine-v1.pdf
211 to 220 of 1000
Previous … 20 21 22 23 24 … Next